Wound Care Demystified: A Comprehensive Review Of Types, Pathophysiology, Global Burden, Therapies, And Future Directions

The body reacts to the dissipated cells following any type of severe injury through the intricate process of wound healing, which is a type of tissue regeneration. Non-healing wounds and diabetes are regarded as unmet clinical needs. Nowadays, a variety of strategic approaches are frequently employed in the management of acute and chronic wounds, which can involve the use of an instrument, cell therapy, tissue transplantation, and wound dressings, among other things. Although a lot of literature has been written about this subject, finding the best clinical treatment is still difficult. In order to deliver medication, autologous stem cells, or growth factors from the blood, the wound dressing uses a scaffold, typically made of biomaterials. In order to prevent infection and hasten wound healing, antibacterial and anti-inflammatory medications are also utilized. There is an urgent need to enhance the current treatment approaches because diabetes and related cutaneous wounds are becoming more common as the population ages. This study critically examines the most recent developments in clinical and therapeutic strategies for tissue regeneration and wound healing. Recent clinical trial results indicate that the simplest, most affordable, and most accessible method of treating chronic wounds is to use contemporary dressings and skin substitutes. Materials science advancements like graphene as a 3D scaffold and biomolecules hold great promise. The annual market value for successful wound treatment exceeds over $50 billion US dollars, and this will encourage industries as well as academics to investigate the application of emerging smart materials for modern dressings and skin substitutes for wound therapy.